 6. Measurable disease after diagnostic biopsy longest axis 1.5 cm for nodal and 1 cm for extranodal lesions andor evaluable disease quantifiable BM infiltrate and 5 x 109l clonal B-cell in peripheral blood in case of exclusive BMleukemic disease in CD5-negative Bcell lymphoma NOS 